Daxor Corporation (DXR) has 20 known insider and institutional holders on record. The largest holder is FELDSCHUH JOSEPH with 2,774,455 shares. Other notable holders include Estate of Joseph Feldschuh and Feldschuh Michael Richard.
Over the last 12 months, insiders have made 10 transactions in DXR stock — 9 buys (valued at $102.8K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
DXR Insider Ownership
Top Holder
FELDSCHUH JOSEPH
2,774,455 shares
Buys (12 mo)
9
$102.8K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Feldschuh Joseph |
10 Percent Owner |
2,774,455 |
2018-03-19 |
|
| 2 |
Estate Of Joseph Feldschuh |
10 Percent Owner |
2,549,455 |
2023-09-20 |
|
| 3 |
Feldschuh Michael Richard |
Chief Executive Officer |
212,694 |
2025-04-07 |
|
| 4 |
Hudson Philip Nordan |
Director |
146,100 |
2012-03-28 |
|
| 5 |
Feldschuh Jonathan Adam |
Chief Scientific Officer |
53,908 |
2025-12-11 |
|
| 6 |
Jefferies John |
Chief Medical Officer |
21,272 |
2026-03-24 |
|
| 7 |
Michel Robert J |
Chief Financial Officer |
21,050 |
2026-03-31 |
|
| 8 |
Willens Robert |
Director |
18,164 |
2013-05-10 |
|
| 9 |
Slovin Bruce |
Director |
5,000 |
2004-05-27 |
|
| 10 |
Feuer Edward |
Director |
2,500 |
2025-06-26 |
|
| 11 |
Lombard James A |
Director |
2,500 |
2023-07-13 |
|
| 12 |
Desrosiers Caleb |
Director |
2,500 |
2025-06-26 |
|
| 13 |
Goudie Joy S. |
Director |
2,500 |
2025-06-26 |
|
| 14 |
Cremisi Henry D. |
Director |
2,500 |
2025-06-26 |
|
| 15 |
Saxe Bernhard |
Director |
2,000 |
2020-07-09 |
|
| 16 |
Wolpoff Martin S |
Director |
2,000 |
2020-07-15 |
|
| 17 |
Thompson Soren |
VP, Business Development |
1,950 |
2018-08-02 |
|
| 18 |
Moussa Robert G |
Director |
1,000 |
2006-10-31 |
|
| 19 |
Fischman Gary Joseph |
President |
1,000 |
2004-12-03 |
|
| 20 |
Valentine Stephen |
Director |
500 |
2005-10-14 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-31 |
Michel Robert J |
Chief Financial Officer |
Informative Buy |
1,000 |
$9.90 |
$9.9K |
| 2026-03-20 |
Jefferies John |
Chief Medical Officer |
Informative Buy |
3,656 |
- |
- |
| 2025-12-09 |
Feldschuh Jonathan Adam |
Chief Scientific Officer |
Informative Buy |
18,000 |
- |
- |
| 2025-12-09 |
Michel Robert J |
Chief Financial Officer |
Informative Buy |
3,000 |
- |
- |
| 2025-11-12 |
Jefferies John |
Chief Medical Officer |
Informative Buy |
2,344 |
- |
- |
| 2025-09-30 |
Jefferies John |
Chief Medical Officer |
Unknown |
147 |
$9.35 |
$1.37K |
| 2025-06-24 |
Desrosiers Caleb |
Director |
RSU Award |
2,500 |
$9.29 |
$23.23K |
| 2025-06-24 |
Goudie Joy S. |
Director |
RSU Award |
2,500 |
$9.29 |
$23.23K |
| 2025-06-24 |
Cremisi Henry D. |
Director |
RSU Award |
2,500 |
$9.29 |
$23.23K |
| 2025-06-24 |
Feuer Edward |
Director |
RSU Award |
2,500 |
$9.29 |
$23.23K |
